A Case of Antithyroid Drug-Induced Agranulocytosis From a Second Antithyroid Drugs (ATD) Administration in a Relapsed Graves' Disease Patient Who Was Tolerant to the First ATD Treatment

Clinical Case Reports - United Kingdom
doi 10.1002/ccr3.1644
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Wiley

Related search

Primary Immune Thrombocytopenia Responding to Antithyroid Treatment in a Patient With Graves’ Disease

Annals of Hematology
MedicineHematology
2010English

Occurrence of ATD-induced Agranulocytosis and Its Treatment

Endocrine Abstracts
2016English

Studies on Onset Patterns in Antithyroid Drug-Induced Agranulocytosis

Folia Endocrinologica Japonica
1993English

Antithyroid Drug-Induced Agranulocytosis Complicated by Pneumococcal Sepsis and Upper Airway Obstruction

Internal Medicine
Internal MedicineMedicine
2013English

Is Radioiodine More Likely Than Antithyroid Drugs to Worsen Ophthalmopathy in Patients With Graves Disease?

Nature Clinical Practice Endocrinology & Metabolism
2008English

Unfavourable Effect of Prolonged Treatment With Antithyroid Drugs on Radioiodine Therapy Outcome in Graves' Hyperthyroidism

Timocki medicinski glasnik
2014English

Hypothyroidism as a Late Sequela in Patients With Graves' Disease Treated With Antithyroid Agents

Journal of Clinical Investigation
Medicine
1979English

Therapeutic Drug Monitoring of Antithyroid Drugs in Pregnancy: The Knowledge Gaps

Therapeutic Drug Monitoring
Pharmacology
2006English

Predictive Value of Gene Polymorphisms on Recurrence After the Withdrawal of Antithyroid Drugs in Patients With Graves’ Disease

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy